新冠病毒对肝病患儿的影响:欧洲小儿胃肠病学、肝脏病学和营养学协会与小儿肝移植协会联合立场文件

2021-10-08 欧洲小儿胃肠病学、肝病学和营养学会(ESPGHAN) J Pediatr Gastroenterol Nutr . 2021 Oct 21

儿童很少受到严重形式的严重新冠病毒 (SARS-CoV2) 感染的影响。然而,合并症对儿童 SARS-CoV2 临床表现和结果的影响尚不明确,包括慢性肝病 (CLD) 和因自身免疫性肝病或肝移植 (L

中文标题:

新冠病毒对肝病患儿的影响:欧洲小儿胃肠病学、肝脏病学和营养学协会与小儿肝移植协会联合立场文件

英文标题:

The Impact of Severe Acute Respiratory Syndrome Coronavirus Type 2 on Children with Liver Diseases: A Joint European Society for Pediatric Gastroenterology, Hepatology and Nutrition and Society of Pediatric Liver Transplantation Position Paper

发布日期:

2021-10-08

简要介绍:

儿童很少受到严重形式的严重新冠病毒 (SARS-CoV2) 感染的影响。然而,合并症对儿童 SARS-CoV2 临床表现和结果的影响尚不明确,包括慢性肝病 (CLD) 和因自身免疫性肝病或肝移植 (LT) 服用免疫抑制药物的患者。虽然不是主要的靶器官,但在感染 SARS-CoV2 的儿童和儿童多系统炎症综合征 (MIS-C) 的儿童中已经描述了一系列肝脏受累。欧洲小儿胃肠病学、肝脏病学和营养学会 (ESPGHAN) 和小儿肝移植学会 (SPLIT) 的肝脏病学委员会提交了一份循证立场文件,内容涉及 SARS-CoV2 感染儿童的肝脏受累及其对感染者的影响CLD 以及 LT 收件人。所有儿童都可能因 SARS-CoV2 感染而出现急性肝损伤,而患有 CLD 的儿童可能会出现肝功能失代偿。讨论了预防和治疗措施。

相关资料下载:
[AttachmentFileName(sort=1, fileName=1.pdf)] GetToolGuiderByIdResponse(projectId=1, id=10dfb1c0022a64f0, title=新冠病毒对肝病患儿的影响:欧洲小儿胃肠病学、肝脏病学和营养学协会与小儿肝移植协会联合立场文件, enTitle=The Impact of Severe Acute Respiratory Syndrome Coronavirus Type 2 on Children with Liver Diseases: A Joint European Society for Pediatric Gastroenterology, Hepatology and Nutrition and Society of Pediatric Liver Transplantation Position Paper, guiderFrom=J Pediatr Gastroenterol Nutr . 2021 Oct 21, authorId=0, author=, summary=儿童很少受到严重形式的严重新冠病毒 (SARS-CoV2) 感染的影响。然而,合并症对儿童 SARS-CoV2 临床表现和结果的影响尚不明确,包括慢性肝病 (CLD) 和因自身免疫性肝病或肝移植 (L, cover=, journalId=0, articlesId=null, associationId=2072, associationName=欧洲小儿胃肠病学、肝病学和营养学会(ESPGHAN), associationIntro=European Society for Pediatric Gastroenterology, Hepatology and Nutrition, copyright=0, guiderPublishedTime=Fri Oct 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0" data-number-of-phrases="1">儿童很少受到严重形式的严重新冠病毒 (SARS-CoV2) 感染的影响。然而,合并症对儿童 SARS-CoV2 临床表现和结果的影响尚不明确,包括慢性肝病 (CLD) 和因自身免疫性肝病或肝移植 (LT) 服用免疫抑制药物的患者。虽然不是主要的靶器官,但在感染 SARS-CoV2 的儿童和儿童多系统炎症综合征 (MIS-C) 的儿童中已经描述了一系列肝脏受累。欧洲小儿胃肠病学、肝脏病学和营养学会 (ESPGHAN) 和小儿肝移植学会 (SPLIT) 的肝脏病学委员会提交了一份循证立场文件,内容涉及 SARS-CoV2 感染儿童的肝脏受累及其对感染者的影响CLD 以及 LT 收件人。所有儿童都可能因 SARS-CoV2 感染而出现急性肝损伤,而患有 CLD 的儿童可能会出现肝功能失代偿。讨论了预防和治疗措施。</span></span></p>, tagList=[TagDto(tagId=99154, tagName=新冠病毒)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2741, appHits=35, showAppHits=0, pcHits=273, showPcHits=2705, likes=0, shares=4, comments=3, approvalStatus=1, publishedTime=Sun Oct 31 08:53:28 CST 2021, publishedTimeString=2021-10-08, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=小小医者, createdTime=Sun Oct 31 08:48:21 CST 2021, updatedBy=6415643, updatedName=凯晨, updatedTime=Thu Jan 04 17:08:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1.pdf)])
1.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1066299, encodeId=d8d110662993d, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 17:28:54 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065508, encodeId=335510655083c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Oct 31 12:19:09 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065484, encodeId=769b1065484c8, content=关注胃肠道, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Sun Oct 31 10:31:29 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2021-11-02 ms6000001387765207

    学习学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1066299, encodeId=d8d110662993d, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 17:28:54 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065508, encodeId=335510655083c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Oct 31 12:19:09 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065484, encodeId=769b1065484c8, content=关注胃肠道, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Sun Oct 31 10:31:29 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2021-10-31 微探

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1066299, encodeId=d8d110662993d, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 17:28:54 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065508, encodeId=335510655083c, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Oct 31 12:19:09 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065484, encodeId=769b1065484c8, content=关注胃肠道, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Sun Oct 31 10:31:29 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2021-10-31 SR~young海东

    关注胃肠道

    0